Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure.

PHASE3CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Heart Failure
Interventions
BIOLOGICAL

Injection of C3BS-CQR-1

Injection of the C3BS-CQR-1 using the C-Cath® injection catheter.

BIOLOGICAL

Sham, no injection

Mimic the injection procedure trough insertion of a sham catheter. No injection actually performed

Trial Locations (35)

1096

Gottsegen György Országos Kardiológiai Intézet - Felnőtt Kardiológiai Osztály, Budapest

1122

Semmelweis Egyetem - Városmajori Szív- és Érgyógyászati Klinika, Budapest

1134

MH Egészségügyi Központ Kardiológiai Osztály, Budapest

1407

City Clinic Cardiology Center Multiprofile Hospital for Active Treatment, Sofia

Multiprofile Hospital for Active Treatment 'Tokuda Hospital Sofia', Sofia

1431

University Multiprofile Hospital for Active Treatment 'Alexandrovska' EAD, Sofia

4000

Centre Hospitalier Universitaire de Liège, Liège

4032

Debreceni Egyetem Orvos - és Egészségtudomanyi Centrum, Debrecen

5530

CHU Mont-Godinne, Yvoir

6042

Hopital Civil Marie Curie, Lodelinsart

6900

Cardiocentro Ticino, Lugano

7624

Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika, Pécs

9300

OLV Ziekenhuis Aalst, Aalst

9600

AZ Glorieux, Ronse

11000

Clinic of Emergency Internal Medicinne Military Medical Academy, Belgrade

Clinical Center of Serbia - Cardiology Clinic, Belgrade

Clinical Centre of Serbia, Cardiology Clinic, Belgrade

Clinical Hospital Center Zvezdara - Cardiology Clinic, Belgrade

11080

Clinical Hospital Center Bezanijska Kosa, Cardiology Dept., Belgrade

13110

Ziv Medical Center - Heart Institute, Safed

16100

Nazareth Hospital EMMS, Nazareth

25123

A.O. Spedali Civili di Brescia, Brescia

28007

Hospital General Universitario Gregorio Marañon, Madrid

28040

Hospital Clinico San Carlos, Madrid

29010

Hospital Clinico Universitario Virgen de la Victoria - Campus de Teatinos s/n, Málaga

37126

AOUI Verona - Borgo Trento Hospital, Verona

38100

Hillel Yaffe Medical Center, Hadera

78278

Barzilai Medical Center - Cardiology Unit, Ashkelon

Unknown

Western Galilee Hospital, Nahariya

80-126

Uniwersyteckie Centrum Kliniczne, KliniczneCentrum Kardiologii, Gdansk

40-635

Górnośląskie Centrum Medyczne Śląskiej Akademii Medycznej, Katowice

31-202

Krakowski Szpital Specjalistyczny im. Jana Pawła II w Krakowie, Krakow

91-347

Biegański Hospital, Lodz

34 000

Clinical Center of Kragujevac,, Kragujevac

08916

Hospital Universitario Germans Trias i Pujol, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celyad Oncology SA

INDUSTRY

NCT01768702 - Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure. | Biotech Hunter | Biotech Hunter